Clinical Trial Update: Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT [NA]

View source ↗

Summary

A completed clinical trial from University of Sao Paulo evaluating how patient vitamin D status may influence actinic keratosis response to MAL-PDT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• MAL-PDT (methyl aminolevulinate photodynamic therapy)

Snippet

Sponsor: University of Sao Paulo | Conditions: Actinic Keratosis | NA | Status: COMPLETED | Results posted: 2020-08-04